Company Data

Travere Therapeutics Inc.

Ticker
TVTX
Current Price
$15.02 -2.34%
Market Cap
$1.3B
Price Target
Refer to Report
Volume
1.9M
52wk Range
$6.49 - $25.29
Advanced Market Data

Overview

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) – rare kidney disorders that often lead to end-stage kidney disease.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy